Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who receive ongoing outpatient care at the University of Chicago Medical Center under a doctor who is participating in this trial
- People who are 18 years of age or older
- People with a life expectancy of at least 3 years
- People who are currently taking between 1 and 6 prescription medications, OR are 65 years or older, OR are reasonably expected to need a prescription medication within the next 5 years
- The trial particularly aims to include people in certain health situations, such as those needing specialist heart care, those with inflammatory bowel disease, those with systemic autoimmune or inflammatory conditions, those needing long-term blood-thinning medication, those with hepatitis C, or those with cancer that has not spread to other parts of the body
Who may not be able to join:
- People with a serious illness — whether short-term or long-term — that could reasonably be expected to result in death within the next 3 years
- People who have had, or are being actively considered for, a liver or kidney transplant
- People who are not able to understand the study information or give their informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter H O'Donnell, MD, University of Chicago
Phone: (773) 834-1759
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of incorporating pharmacogenomic testing into routine medical care
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.